Valeria Caso, President of European Stroke Organisation (ESO), joined Stroke Alliance For Europe (SAFE) and industry partners including Burden of Stroke sponsoring companies coming from Bayer, Boehringer Ingelheim, BMS-Pfizer, Ipsen Biopharm, Amgen, Medtronic. The half day meeting focused on the Burden of Stroke report to be presented in the European Parliament in Brussels on 11 May 2017. Read the meeting report.
SAFE is a non-profit-making organisation that represents a range of stroke patient groups from across Europe. Their mutual goal is to drive stroke prevention up the European political agenda and prevent the incidence of stroke through education.
ESO is a pan-European society of stroke researchers and physicians, national and regional stroke societies and lay organisations. The ESO is comprised of individual and organisational members. The goal of the ESO is to reduce the burden of stroke in Europe.
In order to achieve their goals, both organisations have formally strengthened their partnership through reciprocal organisational membership. This partnership unites stroke physicians with patients to increase advocacy and reduce the burden of stroke in Europe.